(Q30301304)

15 June 2017

title

Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma (English)

1 reference

15 June 2017

1 reference

10

David Reardon

1 reference

15 June 2017

4

Tom Mikkelsen

1 reference

15 June 2017

David Schiff

1

1 reference

15 June 2017

Santosh Kesari

2

1 reference

15 June 2017

John de Groot

3

1 reference

15 June 2017

Jan Drappatz

5

1 reference

15 June 2017

Thomas Coyle

6

1 reference

15 June 2017

Lisa Fichtel

7

1 reference

15 June 2017

Bruce Silver

8

1 reference

15 June 2017

Ian Walters

9

1 reference

15 June 2017

language of work or name

1 reference

13 November 2014

1 reference

Investigational New Drugs

15 June 2017

published in

1 reference

15 June 2017

volume

33

1 reference

15 June 2017

issue

1

1 reference

15 June 2017

page(s)

247-253

1 reference

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

15 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

VEGF Trap induces antiglioma effect at different stages of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

Phase I and pharmacokinetic study of CT-322 (BMS-844203), a targeted Adnectin inhibitor of VEGFR-2 based on a domain of human fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

Bevacizumab and central nervous system (CNS) hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0186-2

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25388940

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The emerging role of new protein scaffold-based agents for treatment of cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25388940

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25388940

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10637-014-0186-2

1 reference

Dimensions Publication ID

15 June 2017

1026426894

0 references

1 reference